Biopôle SA’s innovative life sciences community continues to grow with the addition of Swiss Medical Network, one of Switzerland’s leading private clinic groups. This new partnership will enable Swiss Medical Network to remain at the forefront of medical technology, delivering the highest-quality care to patients from Switzerland and beyond.
Biopôle SA expands its partnership programme with Swiss Medical Network
Operating across all Switzerland, Swiss Medical Network provides its patients with first-class hospital treatment, care and assistance. The group prides itself on its state-of-the-art medical technology and the exceptional calibre of its staff, who are experts in their respective fields.
Biopôle SA brings together pioneers from both academia and industry to nurture collaboration and innovation in life sciences. With access to emerging technologies and unique networks as part of the Biopôle community, Swiss Medical Network (SMN) will help take cutting-edge medical developments from the lab and into hospitals – and ultimately improve patients’ lives.
, Delegate of the Board of Directors at Swiss Medical Network and President of the Genolier Innovation Hub (a private entity already partner of SMN) explains the complementary nature of the partnership: ‘The Genolier Innovation Hub
will host companies that have reached the last phases of their research programmes, with products ready to be tested and implemented in a clinical setting, so companies hosted at Biopôle will enjoy the opportunity to collaborate with SMN and others Healthcare actors during their later clinical trials.’
CEO at Biopôle, commented: ‘We are delighted to welcome Swiss Medical Network to the Biopôle community. Their focus on clinically relevant technological advancements makes them an excellent fit for our world-class network of life sciences innovators.’
Read the interview with Antoine Hubert